Biography:

Carole Wehbe Chidiac is having 20 years’ experience as a Family Medicine Specialist and an Eating Disorder and Obesity Practitioner. She is the Board of Advisers of Middle East Eating Disorders Association and an Active Member of the International Academy of Eating Disorders. She is active in training other health care professionals when it comes to evidence based treatments of obesity and eating disorders. She has given many talks at schools and companies about prevention of obesity and eating disorders. She is also an Aviation Medical Examiner (FAA, GCAA) involved in treating obesity in aviation.

Abstract:

Bariatric surgery and its short-term outcomes have greatly improved. Nevertheless, more knowledge is needed regarding the long-term sustainability of surgically-induced weight loss, subsequent improvement in obesity-related comorbid disease and long term safety. A review of the literature identified a trend suggesting improvements in quality of life and psychological health after bariatric surgery. However, not all patients report these psychological benefits. Some patients continue to struggle with body image dis-satisfaction. Severe pre-operatives psychopathology and patient expectation that life will dramatically change after surgery were found to negatively impact psychological health after surgery. Nutrition deficiencies are common complications after bariatric surgeries and are linked to physical and psychological disorders. Moreover, cases of eating disorders after bariatric surgery are being reported in the literature complicating the long term physical and psychological benefits of bariatric surgery. Medical, surgical, nutritional and psychological evaluation before the surgery is gold standard nowadays even though proper communication between team members is still lacking.

Biography:

Harriet Verkoelen is a Dutch Dietician and Nurse Diabetes Specialist, working in the field of diabetes care for almost 30 years. She wrote three books on the low carb lifestyle and trains dieticians. She trains the diabetes nurses how to advice their patients in the low carb lifestyle and how to lower and stop their diabetes medication.

Abstract:

Treatment of type 2 diabetes mellitus (T2DM), which is usually insulin resistance caused by metabolic syndrome, is mainly by tablets and insulin injections. The treatment protocol starts with a dietary advice which traditionally corresponds to the dietary advice of the World Health Organization (WHO). But when bloodsugarlevels are raised, diabetes medication is prescribed starting with Metformin oral tablets. When bloodsugarlevels are still raised or raise again, Sulfonylurea derivatives (SU) are prescribed in addition. When bloodsugarlevels are still raised or raise again, insulin injections are prescribed in addition. Starting with one injection of long-acting insulin per day. This can be intensified by three injections short-acting insulin per day.

Medical treatment of T2DM often comes with a side-effect which is gaining weight. The problem is that T2DM patients mostly are overweight already. Gaining extra weight by medical treatment causes more health problems. Furthermore, increasing overweight causes more insulin resistance.

Introducing the low carb lifestyle in the treatment of T2DM brings new possibilities. Less insulin is needed when eating less carbohydrates. This way patients with T2DM can postpone or even stop their medical treatment. A second  effect, most importantly, is that the patient will lose weight. This will be beneficial to their health. By losing weight bloodsugarlevels will drop, the blood pressure will also drop, and cholesterol levels will improve (HDL-C and TG). Another effect is that the patient will be less hungry.

In my own dietitians’ office the focus is on losing weight. That is why I advise the low carb lifestyle. The result was that 90% of T2DM patients was able to stop insulin injections. They all lost weight and in 80% HbA1c value improved within half a year. More studies show similar results. These findings show that the current treatment protocol of T2DM patients could be considered to change.

Biography:

Mohammed Alquraishi is a dietician in the Kingdom of Saudi Arabia with the passion of promoting body weight-reduction and maintenance through encouraging healthy dietary habits. Currently, Alquraishi is a PhD student at the department of Nutrition, University of Tennessee at Knoxville, USA. Alquraishi is working under the supervision of Dr. Bettaieb to investigate mixture of bioactive compounds, key enzymes, as well as signaling proteins and their contribution to metabolic diseases such as obesity and type-2 diabetes.

Abstract:

Obesity is a growing epidemic in the United States, affecting more than one-third of adults. There is also a growing body of evidence highlighting the contribution of adipose tissue to systemic inflammatory state that play a potent role in obesity-associated metabolic syndrome and cardiovascular diseases. Zyflamend is a poly-herbal supplement derived from the extracts of ten different herbs effectively activates AMPK in vitro in several cell lines. When activated, AMPK is instrumental in inhibiting anabolic pathways that consume ATP, such as lipogenesis and protein synthesis and enhances catabolic pathways that generate ATP, such as fatty acid oxidation. The effects of Zyflamend on adipogenesis remain largely unknown. The objective of this study was to investigate the effects of Zyflamend treatment on adipogenesis and glucose homeostasis. The report shows the decreased adipogenesis of mouse and human adipocytes in vitro. Moreover, mice treated with Zyflamend exhibited improved glycemic control and enhanced insulin signaling in the muscle and adipose tissue compared with control mice. Further, Zyflamend treatment attenuated chronic HFD-induced Endoplasmic Reticulum (ER) stress in adipose and muscle tissues. Together, these studies identify Zyflamend as a potential treatment for obesity and metabolic syndrome and additional investigation into the mechanism(s) of Zyflamend’s metabolic actions.

Biography:

Dr. Anshoo Agarwal is currently working as Professor & Chairperson at Department of Pathology, Northern Border University, Arar Kingdom of Saudi Arabia. She received her Bachelor of Medicine & Bachelor of Surgery from King George's Medical College Lucknow. Dr. Anshoo Agarwal received her M.D in Pathology from LLRM Medical College / Ch. Charan Singh University. She is an Associate professor and Discipline Coordinator in University Technology MARA,Malaysia. Dr. Anshoo Agarwal has served on many scientific memberships like Life member of Indian Association of Pathology and Microbiology, Member of International Academy Pathology, Life member of Indian Society of Hematology & Transfusion Medicine,Emirates Medical Association Pathology Society. Dr. Anshoo Agarwal has more than 80 publications. Dr. Anshoo Agarwal is editorial member of 3 journals and has many reviewed publications. Dr. Anshoo Agarwal research interests include Advance Haematology & Immunohaematology, Breast cancer and Anticancer vaccines.

Abstract:

Obesity has become one of the major risk factors for chronic diseases later in life. It is a reversible predisposing factor for several debilitating diseases including atherosclerosis, hypertension and diabetes mellitus. So our main goal is to raise awareness among the special care centers and to educate the parents and staff about the risks of obesity and associated disorders and measures to be taken to improve their lifestyle and prevent the complications which may occur in the future in such individuals. This study aimed to determine risk factors by assessing the prevalence of obesity, overweight, central obesity, their associated factors and other diseases in specially challenged children and to educate the parents and care takers about the risk of among them. The study was done based on a pre-structured questionnaire comprising the lifestyle data, in particular, age, sex, ethnicity, medical condition, diet, socioeconomic status, education level, family history of obesity and frequency of physical activity in specially challenged people. Variables including height, weight, height/weight ratio, waist circumference, calculation of BMI were also determined as a requirement to study obesity among them. Diagnosis of obesity and central obesity was confirmed by the WHO standard recommended method by determining of Body Mass Index (BMI) and Waist Circumference (WC). We studied the percentage of specially challenged children who are obese, overweight, have central obesity and are at risk. The study provided information about the changes in lifestyle which are required to avoid the complications and reducing the prevalence of obesity among the specially challenged people. It also helped in educating the parents and care takers of these people regarding risk of cardiovascular disorders and the diseases associated with obesity and among these people. The prevalence of obesity was high indicating that these individuals are prone to chronic diseases in the future, if not intervened at early stages. There is a need to educate the parents and care takers of these people. More health programs should be introduced among these centers to fight the prevalence of obesity and make the health care providers aware of the danger of obesity among them.

Biography:

John Roberts has completed his MA in Social Work Studies at Exeter University. Practising for 12 years as a Cognitive and Behavioural Psychotherapist and Motivational Interviewier, he joined the Improving Access in Psychological Therapies (IAPT) teaching team at Plymouth University in 2007. He has joined the Higher Colleges of Technology (HCT) as a Lecturer in Social Work in 2017. He has managed and led primary and secondary care mental health services in the UK as well as becoming Director for his own independent consulting and treatment company. He has published in Motivational Interviewing and managed through a number of CBT research projects in a clinical setting. He retains an interest in psychological aspects of chronic condition management.

Abstract:

This presentation describes the core components in the assessment formulation and treatment of a single patient with Insulin Dependant Diabetes (IDDM), obesity and features of a multi-impulse control disorder under psychological crisis. The principle treatment was Cognitive and Behavioural Therapy (CBT) for Binge Eating (CBT-BE). In the context of diabetes and binge eating complicated by personality factors this presentation will critically analyse current patient treatment manuals. The presentation also argues for the inclusion of meta-cognitions into manualised treatments as the focus of manuals may be too narrow. This paper conclude that incorporation of schematic-cognitive bias into treatments will lead to improved control of disordered eating and associated impulses. The presentation also evaluates cognitive behavioural group IDDM treatment components and argues for more integrated, idiosyncratic but formulation specific psychological treatment for clinical difficulties of this type.

Biography:

John Roberts has completed his MA in Social Work Studies at Exeter University. Practising for 12 years as a Cognitive and Behavioural Psychotherapist and Motivational Interviewier, he joined the Improving Access in Psychological Therapies (IAPT) teaching team at Plymouth University in 2007. He has joined the Higher Colleges of Technology (HCT) as a Lecturer in Social Work in 2017. He has managed and led primary and secondary care mental health services in the UK as well as becoming Director for his own independent consulting and treatment company. He has published in Motivational Interviewing and managed through a number of CBT research projects in a clinical setting. He retains an interest in psychological aspects of chronic condition management.

Abstract:

This presentation describes the core components in the assessment formulation and treatment of a single patient with Insulin Dependant Diabetes (IDDM), obesity and features of a multi-impulse control disorder under psychological crisis. The principle treatment was Cognitive and Behavioural Therapy (CBT) for Binge Eating (CBT-BE). In the context of diabetes and binge eating complicated by personality factors this presentation will critically analyse current patient treatment manuals. The presentation also argues for the inclusion of meta-cognitions into manualised treatments as the focus of manuals may be too narrow. This paper conclude that incorporation of schematic-cognitive bias into treatments will lead to improved control of disordered eating and associated impulses. The presentation also evaluates cognitive behavioural group IDDM treatment components and argues for more integrated, idiosyncratic but formulation specific psychological treatment for clinical difficulties of this type.

Biography:

Amani Kamal Mohamed Akeelah Saqallah has completed her BSc degree from King Faisal University and had her one year Residency training at King Fahad Educational Hospital, KSA. She had her formal RD training at Kansas State and her Master’s degree in Nutrition Science and Policy with the combination of Public Health at Tufts University, Boston, USA in 2013. She has developed successful nutrition workshops to meet age group educational needs. She designed and implemented innovative programs benefiting public and enhancing their well living skills and self-esteems. She achieved her Health Care MBA and Field Dietitian - Health Researcher Certificate from North Carolina and UAEU. She has joined Zayed University in 2014 and is a freelancer Member at Abu Dhabi CVD Public Health (Weqaya-Nutrition). She has an affiliation with the Emirate Strategic Research Center (ESRC) and her research focus is on behavior change, lifestyle and public health roles in prevention disease such as obesity, DM, cancers and CVD in UAE. She has volunteering roles in several humanitarian agencies and certified as Public Health Ambassador by Abu Dhabi Department of Health since 2015. She is currently a Medical Nutrition Therapy Dietitian and Well-being, Health Coach and Instructor at Zayed University, UAE.

Abstract:

Lose weight is linked with short-term improving and prevention of metabolic risk, but whether these benefits persist over time among UAE national subjects post-bariatric is unknown. The prospective, controlled UAE obese subjects study involved obese subjects who underwent gastric surgery and matched with traditional treated obese control subjects (weight reeducation diet care plan). We report follow-up data for subjects (mean age 30 years; mean body-mass index, 40) who had been followed by a clinical dietitian for 1-2 years (200 subjects) or before the analysis (August 1, 2017). The follow-up rate for laboratory examinations was 80.6% at 2 years. Follow up with dietitian clinic after one and two years, the weight had increased by 0.3% in the control group (diet care plan) and had decreased by 24% in the bariatric surgery group after 2 years, the weight had increased by 1.6% and decreased by 16.%, respectively. Food intake was lower and the physically active subjects higher in the surgery group than in the control group during the observation period. Two year rates of recovery from diabetes, hypertriglyceridemia, low levels of high-density lipoprotein cholesterol, hypertension and hyperuricemia were more positive in the surgery group than in the control group. The surgery group had lower 2-year incidence rates of diabetes, hypertriglyceridemia and hyperuricemia than the control group with considering nutrition intervention and education in both. As compared with usual therapy, bariatric surgery appears to be a good option for the treatment of severe obesity, resulting in long-term weight loss, improved lifestyle, reducing the risk factors with subjects with butting in consideration the good follow-ups of medical nutrition-dietitian clinic interventions in both subjects.